IgG3 antibodies have the highest capacity to fix complement and are consistently associated with protection from malaria in human cohort studies, as such the activation of atypical MBCs by Th1-Tfh may be essential in the development of cytophilic and protective responses. The gene discussed is IGHG3; the disease is malaria.